Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: Global

FIM Rohto BioMed

+ Add to Watchlist

FIMROHA:FH

17.25 EUR 0.000.00%

As of 01:59:30 ET on 02/26/2015.

Snapshot for FIM Rohto BioMed (FIMROHA)

Year To Date: +16.79% 3-Month: +17.75% 3-Year: +29.98% 52-Week Range: 11.42 - 17.25
1-Month: +7.54% 1-Year: +43.63% 5-Year: +18.08% Beta vs NDWUHC: 0.98

Mutual Fund Chart for FIMROHA

No chart data available.
  • FIMROHA:FH 17.36
  • 1M
  • 1Y
Interactive FIMROHA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for FIMROHA

FIM Rohto BioMed is an open-end fund registered in Finland. The Fund's objective is long-term capital appreciation. The Fund invests in shares, and share-related securities of companies operating in the pharmaceuticals sector as well as the biotechnology, food technology and helathcare technology sectors. Emphasis is put on listed European and North American companies.

Inception Date: 05-08-2000 Telephone: 358-9-6134-6380
Managers: TAPANI KOSKENKARI
Web Site: www.fim.com

Fundamentals for FIMROHA

NAV (on 2015-03-02) 17.36
Assets (M) (on 2015-01-30) 53.44
Fund Leveraged N
Minimum Investment 1,000.00
Minimum Subsequent Investment 10.00

Dividends for FIMROHA

No dividends reported

Fees & Expenses for FIMROHA

Front Load 1.00
Back Load 1.00
Current Mgmt Fee 1.70
Redemption Fee 1.00
12b1 Fee -
Expense Ratio 1.81

Top Fund Holdings for FIMROHA

Filing Date: 01/30/2015
Name Position Value % of Total
Pfizer Inc 170,000 4,707,159 8.809%
Johnson & Johnson 31,500 2,794,976 5.230%
Merck & Co Inc 48,000 2,563,743 4.798%
GlaxoSmithKline PLC 130,000 2,538,670 4.751%
Biogen Idec Inc 4,500 1,551,675 2.904%
Actavis plc 6,448 1,522,816 2.850%
Teva Pharmaceutical Industries 30,000 1,511,430 2.828%
Roche Holding AG 6,000 1,437,133 2.689%
Bayer AG 11,000 1,405,932 2.631%
Medtronic PLC 21,500 1,360,181 2.545%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil